STAT5A and breast carcinoma: Moreover, expression/activation of the PRL effector molecule Stat5a was found to associate positively with increased levels of histologic differentiation of breast cancer tissues and to distinguish breast cancer patients with favourable prognosis and response to endocrine therapy32.